Vanga Bhasma: Benefits, Evidence, Dosage & Safety

Q: Does Vanga Bhasma help diabetes?

Traditionally it is prescribed mostly for Prameha (diabetesrelated conditions), and one small openlabel study compared two Vanga Bhasma preparations in 30 type2 diabetes patients over one month (Saini et al., 2021). A related tin preparation lowered fasting blood glucose in diabetic rats (Pak. J. Pharm. Sci.). No highquality human trial exists, so efficacy is unproven: never replace prescribed diabetes medication with it.

Q: Is Vanga Bhasma safe?

Human safety data are limited to one small, short, openlabel study. In rats, acute doses up to 2000 mg/kg caused no deaths, but chronic dosing at five times the therapeutic equivalent produced mild fatty changes and cell infiltration in the kidney and jejunum (Jani & Pandya, 2018). Contamination surveys also show toxic metals above limits are common in Ayurvedic products generally (PMC). Safety data is limited: talk to a clinician.

Q: Why are the warnings so strong for bhasmas?

Because they are herbometallic preparations: the starting materials are metals or minerals, and the safety of the finished product depends entirely on correct classical processing and quality control. Surveys have repeatedly found toxic heavy metals above permissible limits in marketed Ayurvedic products, especially herbometallic ones (PMC). That is why every article in this series insists on qualified supervision and GMPcertified sources.

TL;DR

Vanga Bhasma is calcined tin used in Ayurveda's Rasa Shastra tradition, mostly in Prameha (diabetes-related) conditions. One small open-label study compared two Vanga Bhasma preparations in 30 type-2 diabetes patients over one month. Rat studies show glucose-lowering effects but chronic high doses caused mild kidney and intestinal changes. Evidence is weak: use only under qualified supervision.

(60 words. Sources: Saini et al. 2021, small clinical study; Jani & Pandya 2018, rat toxicity; Trivanga rat study; NCCIH.)

What it is

Vanga is the Ayurvedic name for tin (Sn). Vanga Bhasma is prepared from purified tin through the classical Rasa Shastra sequence of shodhana (purification) and marana (calcination) via repeated puta heating cycles, yielding a fine ash. Transmission electron microscopy of Ayurvedic bhasma samples measured Vanga Bhasma particles at approximately 12.1 nm: within the nanoscale range reported for several classical bhasmas (nanomedicinal study of bhasmas). Like other metallic bhasmas, it is a herbo-mineral preparation, not a nutritional tin supplement: tin is not an established human nutrient.

Traditional use

In Ayurvedic practice, Vanga Bhasma is one of the metallic preparations most commonly prescribed by physicians for Prameha Roga: the classical disease category corresponding to diabetes and urinary disorders (toxicity study of Vanga Bhasma, WJAHR, 2018). Classical texts also describe its use in wasting and debility conditions. These are traditional indications, not clinical proof: the modern evidence is assessed separately below.

What modern research says

Small clinical study in type-2 diabetes

A 2021 comparative clinical study randomized 30 patients with type-2 diabetes (15 per group) to two different Vanga Bhasma preparations at 250 mg twice daily with honey for one month, with follow-up at 15 days and one month (open-label design; DOI: 10.46607/iamj.1109012021). This is the only human study of Vanga Bhasma located: it was small, short, open-label (no blinding or placebo), and assessed Ayurvedic symptom parameters: it does not establish efficacy by modern clinical-trial standards.

Glucose lowering in diabetic rats

Trivanga Bhasma (a related tin-containing preparation) at 200 and 400 mg/kg produced a dose-dependent fall in fasting blood glucose in rats over 15 days, with the maximum reduction at day 15, and caused no observed toxicity or abnormal body-weight changes (Pak. J. Pharm. Sci. study, via WHO EMRO repository). Animal evidence only.

Acute and chronic toxicity in rats

Vanga Bhasma prepared by two different classical methods was tested for acute and chronic toxicity: no mortality or behavioral changes occurred up to the 2000 mg/kg acute limit dose, but chronic administration produced mild fatty changes and cell infiltration in the kidney and jejunum at five times the therapeutic equivalent dose (Jani & Pandya, WJAHR, 2018). A separate review of Vanga Bhasma studies similarly reports no acute toxicity up to 40 times the human therapeutic dose, with only mild kidney cell infiltration and fatty changes in a 90-day chronic study (JAHM review).

What the evidence does not support (yet)

No high-quality randomized, placebo-controlled trial of Vanga Bhasma exists. Whether it meaningfully affects blood sugar, diabetes complications, or any other condition in people is unproven.

Dosage

The only published clinical study used 250 mg twice daily with honey for one month in adults with type-2 diabetes (Saini et al., IAMJ, 2021). This is the dose used in that single small, open-label study: not an established, recommended, or safe dose. Do not self-dose from this figure: bhasma dosing must be individualized by a qualified practitioner, and the chronic rat data show organ changes at multiples of the therapeutic dose (Jani & Pandya, 2018).

Safety & contraindications

Vanga Bhasma is a calcined-tin preparation, and tin has no established nutritional role in humans. The reassuring acute-toxicity findings (no deaths to 2000 mg/kg in rats) do not erase the chronic-study signal: mild fatty changes and cell infiltration in kidney and jejunum at five times the therapeutic equivalent dose (Jani & Pandya, 2018; JAHM review). Animal data cannot establish human safety.

Category-wide contamination data apply: a peer-reviewed survey of 43 Ayurvedic formulations found 73.8% contained mercury, arsenic, or lead above FAO/WHO permissible limits (Ayush limits: lead 10, arsenic 3, cadmium 0.3, mercury 1 µg/g) (PMC survey), and a JAMA-published survey found lead, mercury, or arsenic in 20.7% of Ayurvedic medicines sold online: 40.6% among rasa shastra (herbo-metallic) products (Saper et al., JAMA via PMC). NCCIH warns that some Ayurvedic preparations may contain lead, mercury, or arsenic in amounts that can be toxic (NCCIH: Ayurvedic Medicine: In Depth). India's Department of Ayush mandates heavy-metal testing for exported Ayurvedic medicines (PIB release).

Do not take Vanga Bhasma as a substitute for proven diabetes treatment: uncontrolled diabetes causes irreversible harm, and no quality of evidence supports replacing prescribed medication. Use only under a qualified practitioner, only from a GMP-certified manufacturer, never in pregnancy, breastfeeding, or childhood unless a qualified practitioner specifically advises it. Non-standard preparations may contain untransformed metal and pose real toxicity risks.

FAQs

What is Vanga Bhasma made from?

Vanga Bhasma is made from tin (Vanga), purified and repeatedly calcined through puta heating cycles into a fine ash with particles measured around 12 nm (nanomedicinal bhasma study). It is a herbo-mineral medicine of the Rasa Shastra tradition: not a tin nutritional supplement, since tin is not an established human nutrient.

Does Vanga Bhasma help diabetes?

Traditionally it is prescribed mostly for Prameha (diabetes-related conditions), and one small open-label study compared two Vanga Bhasma preparations in 30 type-2 diabetes patients over one month (Saini et al., 2021). A related tin preparation lowered fasting blood glucose in diabetic rats (Pak. J. Pharm. Sci.). No high-quality human trial exists, so efficacy is unproven: never replace prescribed diabetes medication with it.

What dose was used in the clinical study?

The 2021 study used 250 mg twice daily with honey for one month in adults with type-2 diabetes (Saini et al., 2021). That is a study dose, not a recommendation: the trial was small, short, and open-label, and chronic rat studies show kidney and intestinal changes at five times the therapeutic dose (Jani & Pandya, 2018). Dosing must be set by a qualified practitioner.

Is Vanga Bhasma safe?

Human safety data are limited to one small, short, open-label study. In rats, acute doses up to 2000 mg/kg caused no deaths, but chronic dosing at five times the therapeutic equivalent produced mild fatty changes and cell infiltration in the kidney and jejunum (Jani & Pandya, 2018). Contamination surveys also show toxic metals above limits are common in Ayurvedic products generally (PMC). Safety data is limited: talk to a clinician.

Can I take Vanga Bhasma instead of my diabetes medication?

No. Uncontrolled diabetes causes irreversible damage to eyes, kidneys, nerves, and blood vessels, and no quality of evidence supports replacing proven treatment with Vanga Bhasma (NCCIH). Any Ayurvedic preparation used alongside diabetes care must be coordinated with the treating physician to avoid interactions and gaps in treatment.

Why are the warnings so strong for bhasmas?

Because they are herbo-metallic preparations: the starting materials are metals or minerals, and the safety of the finished product depends entirely on correct classical processing and quality control. Surveys have repeatedly found toxic heavy metals above permissible limits in marketed Ayurvedic products, especially herbo-metallic ones (PMC). That is why every article in this series insists on qualified supervision and GMP-certified sources.

Sources

Saini MK et al. "A comparative clinical study of two Vanga Bhasma preparations in diabetes mellitus (Type-II)." Int. Ayurvedic Medical J., 2021 — Tier 1 (peer-reviewed): open-label randomized study, 15 patients/group, 250 mg BD with honey, 1 month.
Jani J, Pandya K. "Toxicity studies of Vanga Bhasma (incinerated form of tin) prepared by two different methods." WJAHR, 2018 — Tier 1 (peer-reviewed): acute safe to 2000 mg/kg; chronic 5x therapeutic dose — mild fatty changes/cell infiltration in kidney and jejunum.
Pharmaceutical and analytical studies on Vanga Bhasma — JAHM review — Tier 1 (peer-reviewed review): acute no toxicity to 40x human dose; 90-day chronic — only mild kidney changes.
Trivanga bhasma antidiabetic, diuretic and toxicological studies — Pak. J. Pharm. Sci., 2014 — Tier 1 (peer-reviewed, WHO EMRO repository): dose-dependent fasting blood glucose fall in rats at 200/400 mg/kg over 15 days; no observed toxicity.
Improvement of glucose tolerance using Ayurvedic bhasmas in nanomedicinal perspective — Tier 3 (peer-reviewed): TEM particle sizing — Vanga Bhasma ~12.1 nm.
Lead, Mercury, and Arsenic in US- and Indian-Manufactured Ayurvedic Medicines Sold via the Internet — PMC (JAMA) — Tier 1 (peer-reviewed): 20.7% contained lead/mercury/arsenic; 40.6% among rasa shastra products.
Are Ayurvedic medications store house of heavy metals? — PMC — Tier 1 (peer-reviewed): 73.8% of sampled formulations above-limit for mercury, arsenic, or lead; Ayush limits.
NCCIH — Ayurvedic Medicine: In Depth — Tier 2: warning that some Ayurvedic preparations may contain toxic amounts of lead, mercury, or arsenic.
PIB — Testing of heavy metals in herbal medicines must — Tier 1 (Government of India): mandatory heavy-metal testing and labeling for Ayurvedic medicines.

[Triphala Churna](/learn/herbs/triphala-churna) — a classical herbal formula often used in metabolic care
[Ashwagandha](/learn/herbs/ashwagandha) — a well-studied herbal rasayana
[Shatavari](/learn/herbs/shatavari) — a classical herbal rejuvenative
[Tulsi](/learn/herbs/tulsi) — a well-studied Ayurvedic herb for general health

Disclaimer

This article is for educational purposes only and is not medical advice. Vanga Bhasma is a herbo-mineral preparation with no high-quality human efficacy or safety data. Never use it as a substitute for prescribed diabetes treatment, and do not self-administer it. Talk to a qualified healthcare practitioner before use — especially if you are pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.